128 related articles for article (PubMed ID: 11337201)
21. Cholinergic modulation of the hippocampus during encoding and retrieval.
Rogers JL; Kesner RP
Neurobiol Learn Mem; 2003 Nov; 80(3):332-42. PubMed ID: 14521875
[TBL] [Abstract][Full Text] [Related]
22. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.
Chopin P; Colpaert FC; Marien M
J Pharmacol Exp Ther; 2002 Apr; 301(1):187-96. PubMed ID: 11907173
[TBL] [Abstract][Full Text] [Related]
23. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.
Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE
Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478
[TBL] [Abstract][Full Text] [Related]
24. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
Shannon HE; Bemis KG; Hendrix JC; Ward JS
J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
[TBL] [Abstract][Full Text] [Related]
25. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.
Diez-Ariza M; Redondo C; García-Alloza M; Lasheras B; Del Río J; Ramírez MJ
Psychopharmacology (Berl); 2003 Aug; 169(1):35-41. PubMed ID: 12845416
[TBL] [Abstract][Full Text] [Related]
26. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus.
Peterson SL; Purvis RS; Griffith JW
Neurotoxicology; 2005 Dec; 26(6):969-79. PubMed ID: 15890407
[TBL] [Abstract][Full Text] [Related]
27. The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis.
Loeffler JM; Ringer R; Hablützel M; Täuber MG; Leib SL
J Infect Dis; 2001 Jan; 183(2):247-252. PubMed ID: 11110643
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
Dennes RP; Barnes JC
Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
[TBL] [Abstract][Full Text] [Related]
29. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.
Raghavendra V; Chopra K; Kulkarni SK
Neuropeptides; 1998 Oct; 32(5):417-21. PubMed ID: 9845001
[TBL] [Abstract][Full Text] [Related]
30. Cholinergic receptor blockade in prefrontal cortex and lesions of the nucleus basalis: implications for allocentric and egocentric spatial memory in rats.
Nieto-Escámez FA; Sánchez-Santed F; de Bruin JP
Behav Brain Res; 2002 Aug; 134(1-2):93-112. PubMed ID: 12191796
[TBL] [Abstract][Full Text] [Related]
31. Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task.
Sun XL; Ito H; Masuoka T; Kamei C; Hatano T
Biol Pharm Bull; 2007 Sep; 30(9):1727-31. PubMed ID: 17827729
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of alpha-1 adrenergic receptors facilitates spatial learning in rats.
Puumala T; Greijus S; Narinen K; Haapalinna A; Riekkinen P; Sirviö J
Eur Neuropsychopharmacol; 1998 Feb; 8(1):17-26. PubMed ID: 9452936
[TBL] [Abstract][Full Text] [Related]
33. Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.
Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
Psychopharmacology (Berl); 1993; 112(4):415-20. PubMed ID: 7871051
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of cholinergic function in spatial and procedural learning in rats.
von Linstow Roloff E; Harbaran D; Micheau J; Platt B; Riedel G
Neuroscience; 2007 May; 146(3):875-89. PubMed ID: 17418958
[TBL] [Abstract][Full Text] [Related]
35. The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats.
Janas AM; Cunningham SC; Duffy KB; Devan BD; Greig NH; Holloway HW; Yu QS; Markowska AL; Ingram DK; Spangler EL
Life Sci; 2005 Jan; 76(10):1073-81. PubMed ID: 15620572
[TBL] [Abstract][Full Text] [Related]
36. Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus.
Gattu M; Boss KL; Terry AV; Buccafusco JJ
Pharmacol Biochem Behav; 1997 Aug; 57(4):793-9. PubMed ID: 9259008
[TBL] [Abstract][Full Text] [Related]
37. The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse.
Spowart-Manning L; van der Staay FJ
Behav Brain Res; 2004 May; 151(1-2):37-46. PubMed ID: 15084419
[TBL] [Abstract][Full Text] [Related]
38. Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance.
Park CH; Lee YJ; Lee SH; Choi SH; Kim HS; Jeong SJ; Kim SS; Suh YH
J Neurochem; 2000 Jan; 74(1):244-53. PubMed ID: 10617126
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
40. Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.
Barak S; Weiner I
Psychopharmacology (Berl); 2010 Apr; 209(2):175-84. PubMed ID: 20179909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
